We performed Bonferroni correction in our statistical analysis and found no statistical significant associations between CRP and GPC5 SNPs and lung cancer risk, neither in GKN1 polymorphisms nor in response to cisplatin-based chemotherapy, which could be attributed to the relatively small sample size that may not satisfy all the seven independent hypotheses at the same time. This evidence concerns the gene GPC5 and lung cancer.